We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Researchers based in the Canadian province of British Columbia have claimed that so-called "me-too" drugs -- which offer incremental improvements on older, off-patent pharmaceuticals -- account for an overwhelming share of Canada's rising drugs bill.
The UK government should take action over prescription drugs sold over the Internet without safeguards or controls, according to UK-based think tank the Centre for Reform.
Industry sources are calling on South Korea's government to take a more "global" view of innovation to encourage foreign investment in local drug firms.
DRAXIS Health Inc. (TSX: DAX)(Nasdaq: DRAX) has renewed the production outsourcing agreement between its contract manufacturing division and Pfizer Canada Inc., Pfizer Consumer Healthcare division.
Reacting to news item brought out in some section of media, under the title, "JB Chem to buy Russian firm", JB Chemicals & Pharmaceuticals Ltd said on Thursday that, this news report is baseless and incorrect.
GFR Pharmaceuticals Inc. (GFRP) (OTCBB:GFRP) President and CEO, Richard Pierce announced the signing of a Letter of Intent and Plan of Exchange with Harbin Yinhai Technology Development Ltd. (YHT).
A professor at Chiba University on Thursday filed a lawsuit against Astellas Pharma Inc. demanding the company acknowledge him as one of the inventors of a drug used around the world in organ transplants.
Perlegen Sciences, Inc. announced today that it has expanded its relationship with GlaxoSmithKline with an agreement that enables multiple genetics related studies to be conducted over a period of time.
"More than counterfeit drugs, it is high medicine prices that is killing sick Filipinos, depriving them from having proper medication that remains to be priced beyond the reach of ordinary wage-earners."